Skip to main content
SpringerLink
Log in

Ratio Between Metastatic and Examined Lymph Nodes Is an Independent Prognostic Factor After D2 Resection for Gastric Cancer: Analysis of a Large European Monoinstitutional Experience

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: In view of the lack of consensus on the level and number of lymph nodes to be examined for accurate staging of patients with gastric cancer, our aim was to evaluate the prognostic significance of lymph node status in a large European monoinstitutional experience.

Methods: A review was made of our prospective database from 1980 to 2000, when 314 of 445 patients operated for gastric adenocarcinoma underwent radical resection (R0) with D2 lymphadenectomy. Survival was determined by the Kaplan-Meier method and differences were assessed by the log-rank test. Multivariate analysis was performed using the Cox proportional hazards model in forward stepwise regression.

Results: In 277 evaluable patients, 5-year survival was 57% (median follow-up, 48 months; range, 2–251). A total of 7668 lymph nodes were examined (median, 27; range, 11–62). The 5-year survivals according to the metastatic/examined lymph nodes ratio (N ratio) were 14%, 50%, 61%, and 82% in the group of patients with N ratio >25%, 11%–25%, 1%–10%, and 0%, respectively (P < .0001). At multivariate analysis, the N ratio was the best single independent prognostic factor (P = .000).

Conclusions: After R0 resection for gastric cancer, the N ratio is a potent prognostic factor. It should therefore be considered in the clinical decision making process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of US gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer Staging, proximal disease, and the “different disease” hypothesis. Cancer 2000;88:921–32.

    Article  PubMed  CAS  Google Scholar 

  2. Berrino F, Sant M, Verdecchia A, et al. Survival of cancer patients in Europe: the Eurocare study. IARC Sci. Publ. No. 132. Lyon:: International Agency for Research on Cancer, 1995.

    Google Scholar 

  3. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R. Cancer of the stomach: a patient care evaluation study by the American College of Surgeons. Ann Surg 1993;218:583–92.

    Article  PubMed  CAS  Google Scholar 

  4. Siewert JR, Bottcher K, Roder JC, Busch R, Hermanek P, Meyer HJ. Prognostic relevance of lymph node dissection in gastric carcinoma: German Gastric Carcinoma Study Group. Br J Surg 1993;80:1015–8.

    Article  PubMed  CAS  Google Scholar 

  5. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725–30.

    Article  PubMed  CAS  Google Scholar 

  6. Morant R. Neoadjuvant and adjuvant chemotherapy of locally advanced stomach cancer. Onkologie 2001;24:116–21.

    Article  PubMed  CAS  Google Scholar 

  7. Lowe AM, Feig BW, Janjan N, et al. A pilot study of preoperative chemoradiotherapy for resectable gastric cancer. Ann Surg Oncol 2001;8:519–24.

    Article  Google Scholar 

  8. Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology: part I. Jpn J Surg 1981;11:127–39.

    Article  Google Scholar 

  9. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 2nd English ed. Gastric Cancer 1998;1:10–4.

    Article  PubMed  Google Scholar 

  10. Sobin LH, Wittekind CH. International Union Against Cancer (UICC). TNM Classification of Malignant Tumors. 5th ed. New York:: John Wiley 38 Sons, 1997.

    Google Scholar 

  11. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604–8.

    Article  PubMed  CAS  Google Scholar 

  12. Bonder BE. Will Rogers and gastric carcinoma (letter). Arch Surg 1988;123:1023–4.

    Google Scholar 

  13. de Manzoni G, Verlato G, Roviello F, et al. The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer 2002;87:171–4.

    Article  PubMed  CAS  Google Scholar 

  14. Bunt AMG, Hermans J, Smit VTHBM, van de Velde CJH, Fleuren GJ, Brujin JA. Surgical/pathologic-stage migration confronts comparisons of gastric cancer survival rate between Japan and Western countries. J Clin Oncol 1995;13:19–25.

    PubMed  CAS  Google Scholar 

  15. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 2002;9:775–84.

    Article  PubMed  Google Scholar 

  16. Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 2002;9:27–34.

    Article  PubMed  Google Scholar 

  17. Hyung WJ, Noh SH, Yoo CH, et al. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg 2002;26:323–9.

    Article  PubMed  Google Scholar 

  18. Kodera Y, Yamamura Y, Shimizu Y, et al. Lymph node status assessment for gastric carcinoma: is the number of metastatic lymph nodes really practical as a parameter for N categories in the TNM classification? J Surg Oncol 1998;69:15–20.

    Article  PubMed  CAS  Google Scholar 

  19. Siewert JR, Bittcher K, Stein HJ, Roder J. German Gastric Carcinoma Study Group. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:449–61.

    Article  PubMed  CAS  Google Scholar 

  20. Therneau TM, Grambsh PM, Flemming TR. Martingale based residuals for survival models. Biometrika 1990;77:147–60.

    Article  Google Scholar 

  21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–81.

    Article  Google Scholar 

  22. Compton C. LH Sobin for the Cancer Committee, College of American Pathologists, and the Task Force for Protocols on the Examination of Specimens from Patients With Gastric Cancer. Protocol for the examination of specimens removed from patients with gastric carcinoma: a basis for checklists. Arch Pathol Lab Med 1998;122:9–14.

    PubMed  CAS  Google Scholar 

  23. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34:187–220.

    Google Scholar 

  24. Karpeh MS, Leon L, Klimstra D, Brennan MF. Lymph node staging in gastric cancer: is location more important than number? An analysis of 1,038 patients. Ann Surg 2000;232:362–71.

    Article  PubMed  CAS  Google Scholar 

  25. Kato M, Saji S, Kawaguchi Y, et al. A comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage in gastric carcinoma. Hepatogastroenterology 1999;46:3281–6.

    PubMed  CAS  Google Scholar 

  26. Ichikura T, Furuya Y, Tomimatsu S, et al. Relationship between nodal stage and the number of dissected perigastric nodes in gastric cancer. Surg Today 1998;28:879–83.

    Article  PubMed  CAS  Google Scholar 

  27. Hermanek P. The superiority of the new International Union Against Cancer and American Joint Committee on Cancer TNM staging of gastric carcinoma. Cancer 2000;88:1763–5.

    Article  PubMed  CAS  Google Scholar 

  28. Katai H, Yoshinura K, Maruyama K, Sasako M, Sano T. Evaluation of the new International Union Against Cancer TNM staging for gastric carcinoma. Cancer 2000;88:1796–1800.

    Article  PubMed  CAS  Google Scholar 

  29. Bonekamp JJ, Hermans J, Sasako M, van de Velde CJH. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999;340:908–14.

    Article  Google Scholar 

  30. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer. Long term results of the MRC randomised surgical trial. Br J Cancer 1999;79:1522–30.

    Article  PubMed  CAS  Google Scholar 

  31. Brennan MF. Lymph node dissection for gastric cancer. N Engl J Med 1999;340:956–8.

    Article  PubMed  CAS  Google Scholar 

  32. Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial O l. Br J Surg 1997;84:1567–71.

    Article  PubMed  CAS  Google Scholar 

  33. Hundal SA, Macdonald JS, Benedetti J, Fitzsimmons T. Southwest Oncology Group and the Gastric Intergroup. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 2002;9:278–86.

    Article  Google Scholar 

  34. Wanebo HJ, Kennedy BJ, Winchester DP, Fregmen A, Stewart AK. Gastric carcinoma: does lymph node dissection alter the survival? J Am Coll Surg 1996;183:616–24.

    PubMed  CAS  Google Scholar 

  35. Wagner PK, Ramaswamyi A, Schmitz-Moormann P, Rothmund M. Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 1991;78:825–7.

    Article  PubMed  CAS  Google Scholar 

  36. Yu W, Choi GS, Wang I, Suh IS. Comparison of five systems for staging lymph node metastasis in gastric cancer. Br J Surg 1997;84:1305–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncological and Surgical Science, University of Padova, Italy

    Donato Nitti MD, Alberto Marchet MD, Matteo Olivieri MD, Alessandro Ambrosi PhD, Roberto Mencarelli MD, Claudio Belluco MD & Mario Lise MD

  2. Istituto di Clinica Chirurgica Generale II, Università di Padova, Via Giustiniani, 2, 35128, Padova, Italy

    Donato Nitti MD

Authors
  1. Donato Nitti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alberto Marchet MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matteo Olivieri MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alessandro Ambrosi PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roberto Mencarelli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Claudio Belluco MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mario Lise MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Donato Nitti MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nitti, D., Marchet, A., Olivieri, M. et al. Ratio Between Metastatic and Examined Lymph Nodes Is an Independent Prognostic Factor After D2 Resection for Gastric Cancer: Analysis of a Large European Monoinstitutional Experience. Ann Surg Oncol 10, 1077–1085 (2003). https://doi.org/10.1245/ASO.2003.03.520

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.03.520

Key Words

Search

Navigation